US Stock MarketDetailed Quotes
BOLD Boundless Bio
- 2.570
- -0.140-5.17%
Close Nov 21 16:00 ET
- 2.570
- 0.0000.00%
Post 16:20 ET
57.31MMarket Cap-936P/E (TTM)
2.740High2.500Low96.28KVolume2.740Open2.710Pre Close252.06KTurnover0.68%Turnover RatioLossP/E (Static)22.30MShares15.24052wk High0.35P/B36.47MFloat Cap2.50052wk Low--Dividend TTM14.19MShs Float15.240Historical High--Div YieldTTM8.86%Amplitude2.500Historical Low2.618Avg Price1Lot Size
Boundless Bio Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 25.16%18.72M | 38.90%19.39M | 39.68%16.88M | 17.92%54.8M | 14.27%13.8M | 12.84%14.95M | 13.96M | 12.09M | 83.66%46.47M | 12.07M |
| Selling and administrative expenses | 39.84%4.63M | 61.39%4.66M | 45.28%3.75M | 30.60%12.16M | 40.04%3.38M | 32.53%3.31M | --2.89M | --2.58M | 54.57%9.31M | --2.42M |
| -General and administrative expense | 39.84%4.63M | 61.39%4.66M | 45.28%3.75M | 30.60%12.16M | 40.04%3.38M | 32.53%3.31M | --2.89M | --2.58M | 54.57%9.31M | --2.42M |
| Research and development costs | 20.99%14.09M | 33.05%14.74M | 38.16%13.13M | 14.74%42.64M | 7.83%10.41M | 8.27%11.65M | --11.08M | --9.5M | 92.75%37.16M | --9.66M |
| Operating profit | -25.16%-18.72M | -38.90%-19.39M | -39.68%-16.88M | -17.92%-54.8M | -14.27%-13.8M | -12.84%-14.95M | -13.96M | -12.09M | -83.66%-46.47M | -12.07M |
| Net non-operating interest income expense | 24.37%2.17M | 53.58%2.38M | 259.75%1.42M | 690.72%5.28M | 445.45%1.62M | 680.36%1.75M | 1.55M | 395K | 595.83%668K | 297K |
| Non-operating interest income | 24.37%2.17M | 53.58%2.38M | 259.75%1.42M | 690.72%5.28M | 445.45%1.62M | 680.36%1.75M | --1.55M | --395K | 595.83%668K | --297K |
| Other net income (expense) | 0.00%32K | 200.00%33K | 218.52%32K | 180.00%80K | 1,166.67%32K | 32K | 11K | -27K | -1,900.00%-100K | -3K |
| Other non- operating income (expenses) | 0.00%32K | 200.00%33K | 218.52%32K | 180.00%80K | 1,166.67%32K | --32K | --11K | ---27K | -1,900.00%-100K | ---3K |
| Income before tax | -25.32%-16.51M | -36.93%-16.98M | -31.67%-15.43M | -7.70%-49.43M | -3.10%-12.14M | -0.37%-13.17M | -12.4M | -11.72M | -82.07%-45.9M | -11.78M |
| Income tax | ||||||||||
| Net income | -25.32%-16.51M | -36.93%-16.98M | -31.67%-15.43M | -7.70%-49.43M | -3.10%-12.14M | -0.37%-13.17M | -12.4M | -11.72M | -82.07%-45.9M | -11.78M |
| Net income continuous Operations | -25.32%-16.51M | -36.93%-16.98M | -31.67%-15.43M | -7.70%-49.43M | -3.10%-12.14M | -0.37%-13.17M | ---12.4M | ---11.72M | -82.07%-45.9M | ---11.78M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -25.32%-16.51M | -36.93%-16.98M | -31.67%-15.43M | -7.70%-49.43M | -3.10%-12.14M | -0.37%-13.17M | -12.4M | -11.72M | -82.07%-45.9M | -11.78M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -25.32%-16.51M | -36.93%-16.98M | -31.67%-15.43M | -7.70%-49.43M | -3.10%-12.14M | -0.37%-13.17M | -12.4M | -11.72M | -82.07%-45.9M | -11.78M |
| Basic earnings per share | -24.93%-0.74 | 13.11%-0.77 | -1,364.78%-12.27 | -7.59%-3.53 | 35.14%-0.5461 | 36.86%-0.5923 | -0.8862 | -0.8377 | -82.07%-3.281 | -0.842 |
| Diluted earnings per share | -24.93%-0.74 | 13.11%-0.77 | -1,364.78%-12.27 | -7.59%-3.53 | 35.14%-0.5461 | 36.86%-0.5923 | -0.8862 | -0.8377 | -82.07%-3.281 | -0.842 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data